TABLE 3.
Drug |
12 months |
18 months |
||||
---|---|---|---|---|---|---|
All | Exp | Naive | All | Exp | Naive | |
Formoterol | 68±70 | 71±72 | 51±51 | 96±112 | 102±114 | 61±82 |
Form-Budes | 74±70 | 78±72 | 54±54 | 96±105 | 102±108 | 64±81 |
Ipratropium | 58±59 | 60±59 | 54±58 | 70±85 | 73±87 | 64±80 |
Iprat-Salbut | 57±59 | 61±63 | 51±54 | 71±89 | 78±95 | 62±80 |
Salmeterol | 76±70 | 76±71 | 66±66 | 103±112 | 104±111 | 97±122 |
Salmet-Flut | 82±75 | 88±77 | 55±56 | 114±119 | 122±123 | 69±87 |
Tiotropium | 96±78 | 97±79 | 79±71 | 145±133 | 150±135 | 103±108 |
Data presented as mean ± SD days. All Exp versus naive groups, P<0.00001. Form-Budes Formoterol and budesonide; Iprat-Salbut Ipratropium and salbu-tamol; Salmet-Flut Salmeterol and fluticasone